Live attenuated culture-based vaccine against equine rhinopneumonitis (Strain SV/69)

Indications

• Preventive and emergency vaccination against equine rhinopneumonitis
• Recommended for use in endemic and at-risk farms

Description
A live dry vaccine based on an attenuated equine rhinopneumonitis virus, strain SV/69.
It ensures the development of strong and long-lasting immunity after two initial doses and regular annual revaccination.

Target Animals:

• Horses

Immunity and Dosage
Method of use: injections.
Immunity develops within 10–14 days and is strengthened after the second dose.

• Pregnant mares: two doses — first at 1–3 months of gestation, and second 3–4 months later.
• Other horses and foals: two doses, 3–4 months apart.

Revaccination: annually; for sport horses, at least 2 weeks before travel.
Dosage: 2.0 ml subcutaneously; vaccine must be reconstituted before use.